August 21, 2014

Congress wants to limit your access to medical research, even though your tax dollars paid for it

pin it button Congress wants to limit your access to medical research, even though your tax dollars paid for it

HR3699 Congress wants to limit your access to medical research, even though your tax dollars paid for it

by Alliance for Natural Health

Congress wants to limit your access to research—even though your tax dollars paid for it. If this bill passes, you’ll learn only what mainstream medicine wishes you to know. Action Alert!

In 2008, the National Institutes of Health required that all federally funded research publications be made openly available. PubMedCentral (PMC) is a free full-text archive of biomedical and life sciences journal literature at the National Institutes of Health’s National Library of Medicine.

The publishers of the journals weren’t so happy with this new arrangement—they were afraid no one would pay for their publications if the research results were immediately accessible. So the government agreed to give them a full year of journal sales before their research papers had to be posted on PMC, which lets them keep their subscriber base. Journal subscriptions to educational and medical institutions are expensive—and they’re big business.

But even this generous arrangement isn’t good enough for the Association of American Publishers (AAP). The trade group liked the old rules, where they could sell the tax-funded research back to the taxpayers. So the AAP got two members of Congress, Rep. Carolyn Maloney (D-NY) and Rep. Darrell Issa (R-CA), to introduce HR 3699, the Research Works Act, just before the end of 2011.

This bill would prevent the NIH or any other agency from causing or even allowing private-sector research work to be disseminated online without prior consent of both the publisher and the study authors—even if the funding came from our tax dollars.

The AAP weren’t the only publishers involved. Elsevier—the Reed Elsevier Publishing Group, a multinational company that publishes around 2,000 journals and close to 20,000 books and major reference works—happens to be in Rep. Carolyn Maloney’s district, and Elsevier employees made campaign contributions to both Issa and Maloney. (Apparently, it only takes $10,500 to buy two members of Congress.)

Said contributors all work for Tom Reller, vice president for global corporate relations at Elsevier. Interestingly, an email about the bill from Rep. Maloney to one of her critics contained language that was nearly identical to language used by Reller when he was defending the same bill! Are members of Congress employing lobbyists as ghostwriters now?

This is about access to peer-reviewed scientific information—research that we pay for with our tax money. If this bill passes, Americans who want to read the results of federally funded research will have to buy access to each journal article individually—at a cost of $15 or $30 apiece. In other words, as the New York Times recently noted, taxpayers who already paid for the research would have to pay again to read the results.

Access to peer-reviewed scientific research is essential if you are to make informed choices regarding your family’s health—especially if you choose complementary and alternative medicine. Good research will let us choose wisely when it comes to questions of treatment modalities, vaccines, diet, nutrition, and medicine. Right now, supplement companies aren’t even allowed to tell you about the science behind their products, so we must get the scientific information directly from the source.

But that’s just the problem: consumers, integrative doctors, and small businesses might not have the funds to access all these scientific journals—which means your access to the science behind natural products will be limited to what mainstream medicine may wish you to know.

PMC compiles entire studies and has 2.3 million articles going back to 1965. It allows patients, physicians, students, teachers, and advocacy organization like ANH-USA to read about and cite the discoveries that our tax dollars paid for—to keep you informed in these pages, we may review as many as a hundred studies every year. If we needed to pay a publishing company every time we viewed a study which taxpayers have already paid for, we’d be giving thousands of dollars to a publishing company every year instead of protecting your access to natural health.

So what can you do? Two things will make a huge difference!

  • First, help us gain co-sponsors for the Free Speech about Science Act (FSAS). This landmark legislation enables the natural health products community to share peer-reviewed scientific findings about natural health products with the public. The problem, of course, is that if it becomes more difficult for supplement companies and consumers to access the scientific studies themselves, the entire point of FSAS is effectively undermined.
  • The second step is to ask Congress to defeat this new Research Works Act. Please send your message today and explain why limiting access to the results of important studies—which your tax dollars have already paid for—is such a terrible idea. Take action immediately!

Read the full article here: http://www.anh-usa.org/no-science-for-you/

0 commentsback to post

Other articlesgo to homepage

Will India be First Country to Revoke Marketing Licenses for HPV Vaccines?

Will India be First Country to Revoke Marketing Licenses for HPV Vaccines?

Pin It

A petition currently before the Supreme Court of India alleges that the Drugs Controller of India issued licenses for Gardasil and Cervarix without adequate research on safety as directed by the Parliamentary Standing Committee on Health and Family Welfare.

Petition number 558/2012, filed by Kalpana Mehta, Nalini Bhanot and V. Rukmini Rao, seeks to resolve this and several other issues by asking the Supreme Court of India to rescind the licenses for marketing and administration of HPV vaccines, make provisions to identify and treat any girls left with chronic health problems and/or autoimmune disorders after their participation in HPV vaccine trials, blacklist the Program for Appropriate Technology in Health (PATH), and allow no other foreign agencies to have a field presence in India.

Will India be the first country in the world to revoke the marketing licenses for Gardasil and Cervarix? Will the Supreme Court of India move to protect the health and welfare of their young citizens, or the interests of the HPV vaccine manufacturers? Will PATH and similar agencies be banned from operating in India?
Will the victims of adverse reactions to HPV vaccines be located and treated? We can only hope these questions will be answered when the final hearing will take place.

CDC Whistleblower: CDC Covered Up MMR Vaccine Link to Autism in African American Boys

CDC Whistleblower: CDC Covered Up MMR Vaccine Link to Autism in African American Boys

Pin It

A top research scientist working for the Centers for Disease Control and Prevention (CDC) played a key role in helping Dr. Brian Hooker of the Focus Autism Foundation uncover data manipulation by the CDC that obscured a higher incidence of autism in African-American boys.

“We’ve missed ten years of research because the CDC is so paralyzed right now by anything related to autism. They’re not doing what they should be doing because they’re afraid to look for things that might be associated.” The whistleblower alleges criminal wrongdoing of his supervisors, and he expressed deep regret about his role in helping the CDC hide data.

The Cancer Industry is Too Prosperous to Allow a Cure

The Cancer Industry is Too Prosperous to Allow a Cure

Pin It

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it.

800,000 Die from Blindly Trusting Their Doctor’s Prescription for This Pre-Surgery Drug

800,000 Die from Blindly Trusting Their Doctor’s Prescription for This Pre-Surgery Drug

Pin It

European doctors may have caused as many as 800,000 deaths in five years by following the “standard of care” to use beta-blockers in non-cardiac surgery patients—a guideline based largely on discredited science.

Tylenol: The Killer Drug Your Children can Buy

Tylenol: The Killer Drug Your Children can Buy

Pin It

Is there any more doubt that acetaminophen (Tylenol) is the most dangerous over-the-counter drug ever allowed to be sold legally without a prescription? Consider the facts:

Acetaminophen kills almost 500 people a year due to acute liver failure.
Acetaminophen overdose is the leading cause for calls to Poison Control Centers – more than 100,000/year.
Acetaminophen accounts for more than 56,000 emergency room visits, 2,600 hospitalizations.
Acetaminophen poisoning causes nearly 50% of all acute liver failure in the United States.
Acetaminophen is linked to fatal skin reactions.
Acetaminophen causes a two-fold increased risk of blood cancer.
Acetaminophen can cause an increase in autism, attention deficit with hyperactivity, and asthma when used with vaccines.

And yet, any child can walk into a drug store or grocery store and buy it like candy. Alliance for Natural Health brings us the latest bad news on Tylenol:

A study just published in JAMA Pediatrics finds that Tylenol (acetaminophen) taken by women during their pregnancy may raise the risk of ADHD (Attention Deficit Hyperactive Disorder) and similar disorders in their children up to 40%—with the risk increasing the more acetaminophen the mother takes.

read more


Get the news right in your inbox!